Thrombotic thrombocytopenic purpura complicating interferon therapy in chronic C hepatitis.
Sallée
M
M
Crétel
E
E
Jean
R
R
Chiche
L
L
Bourlière
M
M
Poullin
P
P
Lefèvre
P
P
Durand
J-M
JM
D051722:ADAM Proteins / Q000276:immunology; D000071120:ADAMTS13 Protein; D000998:Antiviral Agents / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007155:Immunologic Factors / Q000009:adverse effects*; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced*; D014841:von Willebrand Factor / Q000276:immunology
D000998:Antiviral Agents; D007074:Immunoglobulin G; D007155:Immunologic Factors; D016898:Interferon-alpha; D014841:von Willebrand Factor; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human